Sign in
The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial
Journal article   Open access   Peer reviewed

The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial

J.T. Denholm, J. Davis, D. Paterson, J. Roberts, S. Morpeth, T. Snelling, D. Zentner, M. Rees, M. O’Sullivan, D. Price, …
Trials, Vol.21(1), Art. 646
2020
pdf
ASCOT.pdfDownloadView
Published (Version of Record) Open Access
url
Free to Read *No subscription requiredView

Abstract

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

46 File views/ downloads
84 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.14 Nursing
1.14.703 Electronic Health Records
Web Of Science research areas
Medicine, Research & Experimental
ESI research areas
Clinical Medicine
Logo image